Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material

NCT07403825 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Macular Degeneration, Age Related

Interventions

DRUG: Vabysmo 6 MG in 0.05 ML Injection

Sponsor

Biobizkaia Health Research Institute

Collaborators

[object Object]